Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower-Reference-Cited by-同舟云学术

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower

Published:2008-11-15 Issue:10 Volume:113 Page:2695-2703
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Walz Jochen,Haese Alexander,Scattoni Vincenzo,Steuber Thomas,Chun Felix K. H.,Briganti Alberto,Montorsi Francesco,Graefen Markus,Huland Hartwig,Karakiewicz Pierre I.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.23885/fullpdf

Reference27 articles.

1. EAU guidelines on prostate cancer;Aus;Eur Urol.,2005

2. Network NCC. NCCN Clinical Practice Guidelines in Oncology, Prostate Cancer Early Detection. 2006. Available at: http://www.nccn.org/professionals/physicians_gls/PDF/prostate.pdf. Accessed on January 12, 2008.

3. The influence of finasteride on the development of prostate cancer;Thompson;N Engl J Med.,2003

4. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter;Thompson;N Engl J Med.,2004

5. Prostate cancer detection in the prostate specific antigen range of 2.0 to 3.9 ng/ml: value of percent free prostate specific antigen on tumor detection and tumor aggressiveness;Raaijmakers;J Urol.,2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer screening through surface-enhanced Raman spectroscopy fingerprinting analysis of urinary metabolites using surface-carbonized silver nanowires on a filter membrane;Analytica Chimica Acta;2024-03

2. Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS);Journal of Urology;2023-10

3. The role of inflammatory processes and zinc levels in prostatic enlargement among Iraqi samples;Journal of Medicine and Life;2023-09

4. A comprehensive comparison between mpMRI of the prostate, MR-US fusion biopsy and whole mount histopathology;World Journal of Urology;2023-02-25

5. The value of bone scans to predict survival time in patients with diagnosed prostate cancer: single-center retrospective study;Journal of Radiology and Oncology;2022-05-25